CNYX-001
Asset
- Stage
- Preclinical
- Modality
- Other
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Retinitis pigmentosa
Preclinical, prnewswire.com, Oct 27, 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.